Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pathobiotek gains US patent for "activating virus"

This article was originally published in Clinica

Executive Summary

Pathobiotek Diagnostics has been awarded a US patent covering tests for a virus thought to be associated with a number of cancers and immunodeficiency diseases. The "activating virus", which has not yet been fully characterised but is believed to be a herpes virus, was discovered in marmosets with wasting syndrome, a condition that resembles AIDS in humans. Pathobiotek has also been awarded a notice of allowance on a patent covering the Leuy bacterium, which is implicated in the aetiology of multiple sclerosis.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT069774

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel